Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome

Germline variations in the DNA polymerase genes, POLE and POLD1, can lead to a hereditary cancer syndrome that is characterized by frequent gastrointestinal polyposis and multiple primary malignant tumors. However, because of its rare occurrence, this disorder has not been extensively studied. In th...

Full description

Bibliographic Details
Main Authors: Ying Zhang, Xiaolu Wang, Yuning Zhu, Chong Liang, Lijun Zhao, Qi Meng, Jiani C. Yin, Yuqian Shi, Fufeng Wang, Feng Qin, Ji Xuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1222873/full
_version_ 1797691147589517312
author Ying Zhang
Xiaolu Wang
Yuning Zhu
Chong Liang
Lijun Zhao
Qi Meng
Jiani C. Yin
Yuqian Shi
Fufeng Wang
Feng Qin
Ji Xuan
author_facet Ying Zhang
Xiaolu Wang
Yuning Zhu
Chong Liang
Lijun Zhao
Qi Meng
Jiani C. Yin
Yuqian Shi
Fufeng Wang
Feng Qin
Ji Xuan
author_sort Ying Zhang
collection DOAJ
description Germline variations in the DNA polymerase genes, POLE and POLD1, can lead to a hereditary cancer syndrome that is characterized by frequent gastrointestinal polyposis and multiple primary malignant tumors. However, because of its rare occurrence, this disorder has not been extensively studied. In this report, we present the case of a 22-year-old female patient who had been diagnosed with gastrointestinal polyposis, breast fibroadenoma, multiple primary colorectal cancers, and glioblastoma (grade IV) within a span of 4 years. Next-generation sequencing analysis revealed a germline variant in POLD1 (c.1816C>A; p.L606M). In silico analysis using protein functional predicting software, including SIFT, Polyphen, GERP++, and CADD, further confirmed the pathogenicity of POLD1 p.L606M (classified as ACMG grade Class 4). In line with polymerase deficiency, both rectal cancer and glioblastoma tissues exhibited a high tumor mutation burden, with 16.9 muts/Mb and 347.1 muts/Mb, respectively. Interestingly, the patient has no family history of cancer, and gene examination of both parents confirms that this is a de novo germline variant. Therefore, molecular screening for POLD1 may be necessary for patients with such a cancer spectrum, regardless of their family history.
first_indexed 2024-03-12T02:09:12Z
format Article
id doaj.art-6943fd05bac84e619679c8fa30947a33
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-12T02:09:12Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-6943fd05bac84e619679c8fa30947a332023-09-06T16:26:46ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-09-011310.3389/fonc.2023.12228731222873Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndromeYing Zhang0Xiaolu Wang1Yuning Zhu2Chong Liang3Lijun Zhao4Qi Meng5Jiani C. Yin6Yuqian Shi7Fufeng Wang8Feng Qin9Ji Xuan10Department of Pathology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, ChinaDepartment of Oncology, The Affiliated Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaDepartment of Pathology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, ChinaDepartment of Neurosurgery Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, ChinaMedical Science Liaison, Genetron Health Inc., Beijing, ChinaGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, ChinaGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, ChinaGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, ChinaGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, ChinaCancer Center, Jinling Hospital, Nanjing University School of Medicine, Nanjing, ChinaDepartment of Gastroenterology, Jinling Hospital, Nanjing University, School of Medicine, Nanjing, ChinaGermline variations in the DNA polymerase genes, POLE and POLD1, can lead to a hereditary cancer syndrome that is characterized by frequent gastrointestinal polyposis and multiple primary malignant tumors. However, because of its rare occurrence, this disorder has not been extensively studied. In this report, we present the case of a 22-year-old female patient who had been diagnosed with gastrointestinal polyposis, breast fibroadenoma, multiple primary colorectal cancers, and glioblastoma (grade IV) within a span of 4 years. Next-generation sequencing analysis revealed a germline variant in POLD1 (c.1816C>A; p.L606M). In silico analysis using protein functional predicting software, including SIFT, Polyphen, GERP++, and CADD, further confirmed the pathogenicity of POLD1 p.L606M (classified as ACMG grade Class 4). In line with polymerase deficiency, both rectal cancer and glioblastoma tissues exhibited a high tumor mutation burden, with 16.9 muts/Mb and 347.1 muts/Mb, respectively. Interestingly, the patient has no family history of cancer, and gene examination of both parents confirms that this is a de novo germline variant. Therefore, molecular screening for POLD1 may be necessary for patients with such a cancer spectrum, regardless of their family history.https://www.frontiersin.org/articles/10.3389/fonc.2023.1222873/fullNGSPOLD1POLEgermline POLD1 L606Mpolyposis syndrome
spellingShingle Ying Zhang
Xiaolu Wang
Yuning Zhu
Chong Liang
Lijun Zhao
Qi Meng
Jiani C. Yin
Yuqian Shi
Fufeng Wang
Feng Qin
Ji Xuan
Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome
Frontiers in Oncology
NGS
POLD1
POLE
germline POLD1 L606M
polyposis syndrome
title Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome
title_full Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome
title_fullStr Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome
title_full_unstemmed Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome
title_short Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome
title_sort case report cancer spectrum and genetic characteristics of a de novo germline pold1 p l606m variant induced polyposis syndrome
topic NGS
POLD1
POLE
germline POLD1 L606M
polyposis syndrome
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1222873/full
work_keys_str_mv AT yingzhang casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT xiaoluwang casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT yuningzhu casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT chongliang casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT lijunzhao casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT qimeng casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT jianicyin casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT yuqianshi casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT fufengwang casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT fengqin casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome
AT jixuan casereportcancerspectrumandgeneticcharacteristicsofadenovogermlinepold1pl606mvariantinducedpolyposissyndrome